These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 19493247)

  • 41. Autoimmunity and gestational diabetes.
    Sharma R; Misra A
    Natl Med J India; 1993; 6(6):272-3. PubMed ID: 7950934
    [No Abstract]   [Full Text] [Related]  

  • 42. Autoimmunity and pediatric movement disorders.
    Singer HS; Williams PN
    Adv Neurol; 2006; 99():166-78. PubMed ID: 16536363
    [No Abstract]   [Full Text] [Related]  

  • 43. Prevalence of type 2 diabetes mellitus in the pediatric population of a third-level care hospital in Mexico City in 2013 and 2018.
    Molina-Díaz JM; Vargas-Terrez BE; Medina-Bravo PG; Martínez-Ambrosio A; Miranda-Lora AL; Klünder-Klünder M
    World J Diabetes; 2023 Mar; 14(3):290-298. PubMed ID: 37035230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Indices of insulin secretion during a liquid mixed-meal test in obese youth with diabetes.
    Bacha F; Gungor N; Lee S; de las Heras J; Arslanian S
    J Pediatr; 2013 May; 162(5):924-9. PubMed ID: 23290511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study.
    Klingensmith GJ; Pyle L; Arslanian S; Copeland KC; Cuttler L; Kaufman F; Laffel L; Marcovina S; Tollefsen SE; Weinstock RS; Linder B;
    Diabetes Care; 2010 Sep; 33(9):1970-5. PubMed ID: 20519658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical trials in youth with type 2 diabetes.
    Gemmill JA; Brown RJ; Nandagopal R; Rodriguez LM; Rother KI
    Pediatr Diabetes; 2011 Feb; 12(1):50-7. PubMed ID: 20456085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Roundtable. Blueprint for conversion of patients on metformin and sulfonylurea to Glucovance.
    Roselli A; Hayes JD; Seidner R; Marchione V; Snyder CM; Mayes K; Stiernberg CM; Milgram L
    Manag Care; 2001 Feb; 10(2 Suppl):17-21. PubMed ID: 11729404
    [No Abstract]   [Full Text] [Related]  

  • 48. Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancer.
    Prescrire Int; 2009 Jun; 18(101):115. PubMed ID: 19637427
    [No Abstract]   [Full Text] [Related]  

  • 49. Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes.
    Jones MR; Mudaliar S; Hernandez-Triana E; Unnikrishnan AG; Lai YL; Abby SL; Misir S; Jin X; Nagendran S
    Curr Med Res Opin; 2009 Sep; 25(9):2239-49. PubMed ID: 19622007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Janumet.
    PAPR
    JAAPA; 2007 Jun; 20(6):14. PubMed ID: 17605185
    [No Abstract]   [Full Text] [Related]  

  • 51. Ethnic origin is unrelated to autoimmunity and residual pancreatic function in 471 youth with clinically diagnosed type 2 diabetes.
    Gottschalk M; Danne T; Fuerst-Recktenwald S
    Pediatr Diabetes; 2009 Jun; 10(4):240-7. PubMed ID: 19493247
    [No Abstract]   [Full Text] [Related]  

  • 52. Oral hypoglycemic agents and heart.
    Manoria P; Manoria P
    Indian Heart J; 2007; 59(3):266-72. PubMed ID: 19124937
    [No Abstract]   [Full Text] [Related]  

  • 53. Selecting among ADA/EASD tier 1 and tier 2 treatment options.
    McGill JB
    J Fam Pract; 2009 Sep; 58(9 Suppl Treating):S26-34. PubMed ID: 19744422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical management of type 2 diabetes in indigenous youth.
    Sellers EA; Moore K; Dean HJ
    Pediatr Clin North Am; 2009 Dec; 56(6):1441-59. PubMed ID: 19962030
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.